Receptors, Estrogen Concept

subject area of

• 17HSD 2 may be higher in African-American breast cancer and is associated with estrogen receptor-negative tumors.  Academic Article
• 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years  Academic Article
• BRCA1 and BRCA2 Mutation Carriers, Oral Contraceptive Use, and Breast Cancer Before Age 50  Academic Article
• A TOXICITY IDENTIFICATION EVALUATION APPROACH TO STUDYING ESTROGENIC SUBSTANCES IN HOG MANURE AND AGRICULTURAL RUNOFF  Academic Article
• A machine learning approach to radiogenomics of breast cancer: a study of 922 subjects and 529 DCE-MRI features  Academic Article
• A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer  Academic Article
• Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer  Academic Article
• Adjuvant Therapy for Breast Cancer: We Are Solving the Puzzle, But Pieces Are Still Missing  Academic Article
• Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial  Academic Article
• Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials  Academic Article
• Adjuvant endocrine therapies for pre-/perimenopausal women  Academic Article
• American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Status Report 2004  Academic Article
• American Society of Clinical Oncology Technology Assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: Status report 2004  Academic Article
• An improved statistical approach: Can it clarify the role of new prognostic factors for breast cancer?  Academic Article
• An investigation of cut-points for primary breast cancer oestrogen and progesterone receptor assays  Academic Article
• Anti-Inflammatory Effects of Tanshinone IIA on Atherosclerostic Vessels of Ovariectomized ApoE-/- Mice are Mediated by Estrogen Receptor Activation and Through the ERK Signaling Pathway  Academic Article
• Aromatase Inhibitor Exemestane has Antiproliferative Effects on Human Mesothelioma Cells  Academic Article
• Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials  Academic Article
• Assessing wild fish exposure to ligands for sex steroid receptors from pulp and paper mill effluents in the Biobio River Basin, Central Chile  Academic Article
• Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer  Academic Article
• Association of low tumor RNA integrity with response to chemotherapy in breast cancer patients  Academic Article
• Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer  Academic Article
• BRCA2 Mutation-associated Breast Cancers Exhibit a Distinguishing Phenotype Based on Morphology and Molecular Profiles From Tissue Microarrays  Academic Article
• Beneficial effects of resveratrol on respiratory chain defects in patients' fibroblasts involve estrogen receptor and estrogen-related receptor alpha signaling  Academic Article
• Breast Cancer Prevention with Selective Estrogen Receptor Modulators  Academic Article
• Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort study  Academic Article
• Breast cancer prognostic significance of a single nucleotide polymorphism in the proximal androgen response element of the prostate specific antigen gene promoter  Academic Article
• CYP3C gene regulation by the aryl hydrocarbon and estrogen receptors in zebrafish  Academic Article
• Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer  Academic Article
• Cancer Care Ontario Guideline Recommendations for Hormone Receptor Testing in Breast Cancer  Academic Article
• Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer.  Conference Paper
• Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor–Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial  Academic Article
• Correlative Analysis of Genetic Alterations and Everolimus Benefit in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From BOLERO-2  Academic Article
• Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression  Academic Article
• Development of Patients’ Decision Aid for Older Women With Stage I Breast Cancer Considering Radiotherapy After Lumpectomy  Academic Article
• Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status  Academic Article
• Discordance between Receptor Status in Primary and Metastatic Breast Cancer: an Exploratory Study of Bone and Bone Marrow Biopsies  Academic Article
• Do selective serotonin receptor inhibitor antidepressants reduce tamoxifen's effectiveness and increase the risk of death from breast cancer?  Academic Article
• Downregulation of CYB5D2 is associated with breast cancer progression  Academic Article
• Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial  Academic Article
• EMSY and CCND1 amplification in familial breast cancer: from the Ontario site of the Breast Cancer Family Registry  Academic Article
• Effect Modification by Catalase Genotype Suggests a Role for Oxidative Stress in the Association of Hormone Replacement Therapy with Postmenopausal Breast Cancer Risk  Academic Article
• Effect of Everolimus on Bone Marker Levels and Progressive Disease in Bone in BOLERO-2  Academic Article
• Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer  Academic Article
• Effect of continuous statistically standardized measures of estrogen and progesterone receptors on disease-free survival in NCIC CTG MA.12 Trial and BC Cohort  Academic Article
• Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials  Academic Article
• Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer  Academic Article
• Effects of Genistein or Soy Milk During Late Gestation and Lactation on Adult Uterine Organization in the Rat  Academic Article
• Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93  Academic Article
• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials  Academic Article
• Efficacy of Letrozole Extended Adjuvant Therapy According to Estrogen Receptor and Progesterone Receptor Status of the Primary Tumor: National Cancer Institute of Canada Clinical Trials Group MA.17  Conference Paper
• Endocrine disruption mechanism of o,p′-DDT in mature male tilapia (Oreochromis niloticus)  Academic Article
• Endocrinology and hormone therapy in breast cancer: Endocrine therapy in premenopausal women  Academic Article
• Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination  Academic Article
• Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2– Advanced Breast Cancer  Academic Article
• Enzyme-linked immunoabsorbent assay-detected p53 protein accumulation: a prognostic factor in a large breast cancer cohort.  Conference Paper
• ErbB Receptor Signaling and Therapeutic Resistance to Aromatase Inhibitors  Conference Paper
• Estrogen and progesterone binding sites in renal cell carcinoma  Academic Article
• Estrogen and progesterone receptor content of primary and secondary breast carcinoma: Influence of time and treatment  Academic Article
• Estrogen independent gene expression defines clinically relevant subgroups of estrogen receptor positive breast cancer  Academic Article
• Estrogen receptor of breast cancer stem cells depending on the original breast cancers  Academic Article
• Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors  Academic Article
• Estrogen receptor: is it predictive for response to cytotoxic as well as hormonal therapy?  Academic Article
• Etiology of Hormone Receptor–Defined Breast Cancer: A Systematic Review of the Literature  Academic Article
• Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis  Academic Article
• Expression of HER2neu in Ductal Carcinoma in situ is Associated with Local Recurrence  Academic Article
• Fenretinide in the prevention of breast cancer in premenopausal women: fluke or fact?  Academic Article
• First-Line Bevacizumab-Containing Therapy for Triple-Negative Breast Cancer: Analysis of 585 Patients Treated in the ATHENA Study  Academic Article
• First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients  Academic Article
• Health-related quality of life and disease symptoms in postmenopausal women with HR⁺, HER2⁻advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy  Academic Article
• High Coffee Intake, but Not Caffeine, is Associated with Reduced Estrogen Receptor Negative and Postmenopausal Breast Cancer Risk with No Effect Modification by CYP1A2 Genotype  Academic Article
• Hormone Receptor and ERBB2 Status in Gene Expression Profiles of Human Breast Tumor Samples  Academic Article
• Identification of a Novel Luminal Molecular Subtype of Breast Cancer  Academic Article
• Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators  Academic Article
• Immunofluorometrically determined p53 accumulation as a prognostic indicator in italian breast cancer patients  Academic Article
• Immunohistochemical evidence for estrogen receptors in meibomian glands  Academic Article
• Incidence of Brain Metastases in Nonmetastatic and Metastatic Breast Cancer: Is There a Role for Screening?  Academic Article
• Induction of hTERT Expression and Telomerase Activity by Estrogens in Human Ovary Epithelium Cells  Academic Article
• Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies  Academic Article
• Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes  Academic Article
• Insulin-like growth factor–binding protein-3 and breast cancer survival  Academic Article
• Interactions between endosulfan and dieldrin on estrogen-mediated processes in vitro and in vivo  Academic Article
• Intra-tumor molecular heterogeneity in breast cancer: definitions of measures and association with distant recurrence-free survival  Academic Article
• Invasive lobular carcinoma: to grade or not to grade  Academic Article
• Is Leptin a Mediator of Adverse Prognostic Effects of Obesity in Breast Cancer?  Academic Article
• Lifetime adult weight gain, central adiposity, and the risk of pre- and postmenopausal breast cancer in the Western New York exposures and breast cancer study  Academic Article
• Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy  Academic Article
• Loss of Antigenicity in Stored Sections of Breast Cancer Tissue Microarrays  Academic Article
• Managing Patients on Endocrine Therapy: Focus on Quality-of-Life Issues  Academic Article
• Managing patients on endocrine therapy: Focus on quality-of-life issues  Conference Paper
• Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies  Academic Article
• Micronutrients Involved in One-Carbon Metabolism and Risk of Breast Cancer Subtypes  Academic Article
• Nuclear Kaiso Expression Is Associated with High Grade and Triple-Negative Invasive Breast Cancer  Academic Article
• Oestrogen receptor downregulation: an opportunity for extending the window of endocrine therapy in advanced breast cancer  Academic Article
• Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer  Academic Article
• Optimal Chemotherapy for Women With Breast Cancer: The Plot Thickens  Academic Article
• Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05)  Academic Article
• Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27  Academic Article
• Ovarian suppression/ablation in premenopausal ER-positive breast cancer patients. Issues and recommendations.  Academic Article
• Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: Primary results from PALOMA-4  Academic Article
• Performance of preoperative breast MRI based on breast cancer molecular subtype  Academic Article
• Pharmacokinetics, safety, activity, and biomarker analysis of palbociclib plus letrozole as first-line treatment for ER+/HER2– advanced breast cancer in Chinese women  Academic Article
• Phase II study of lonidamine in patients with metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group Study.  Academic Article
• Phytoestrogen intake from foods, during adolescence and adulthood, and risk of breast cancer by estrogen and progesterone receptor tumor subgroup among Ontario women  Academic Article
• Pleural effusion in breast cancer. Thoracoscopy for hormone receptor determination  Academic Article
• Polychemotherapy for early breast cancer: an overview of the randomised trials  Academic Article
• Polycomb complex protein BMI1 confers resistance to tamoxifen in estrogen receptor positive breast cancer  Academic Article
• Postmenopausal breast cancer: is the short-term pain worth the long-term gain?  Academic Article
• Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker  Academic Article
• Predictive Significance of an Optimized Panel for Basal-like Breast Cancer: Results from the Canadian Cancer Trials Group MA.5 and MA.12 Phase III Clinical Trials  Academic Article
• Preparation and Evaluation of Carborane Analogues of Tamoxifen  Academic Article
• Primary tumor and patient characteristics in breast cancer as predictors of adjuvant therapy regimen: a regression model  Academic Article
• Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: Conference Summary Statement  Conference Paper
• Progesterone Receptor Loss Correlates with Human Epidermal Growth Factor Receptor 2 Overexpression in Estrogen Receptor–Positive Breast Cancer  Conference Paper
• Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial  Academic Article
• Prognostic value of prostate-specific antigen for women with breast cancer: a large United States cohort study.  Academic Article
• Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario  Academic Article
• Prospective Validation of a 21-Gene Expression Assay in Breast Cancer  Academic Article
• Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer.  Academic Article
• Quantitative analysis of mutant p53 protein in breast tumor cytosols and study of its association with other biochemical prognostic indicators in breast cancer  Academic Article
• Quantitative dot blot analyses of blood-group-related antigens in paired normal and malignant human breast tissues  Academic Article
• RELEVANCE OF THE HORMONE RECEPTOR CONTENT OF PRIMARY TUMORS IN PATIENTS WITH ADVANCED BREAST-CANCER UNDERGOING CYTOTOXIC CHEMOTHERAPY  Academic Article
• Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study  Academic Article
• Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17  Academic Article
• Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group. Breast Cancer Site Group.  Academic Article
• Receptor-interacting protein 140 interacts with and inhibits transactivation by, peroxisome proliferator-activated receptor α and liver-X-receptor α  Academic Article
• Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative  Academic Article
• Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia  Academic Article
• Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14  Academic Article
• Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2)  Academic Article
• Role and mechanism of action of tamoxifen in premenopausal women with metastatic breast carcinoma.  Academic Article
• Role of Estrogen in Type 1 and Type 2 Diabetes Mellitus: A Review of Clinical and Preclinical Data  Academic Article
• S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situof the breast  Academic Article
• Safety and Efficacy of Everolimus With Exemestane vs. Exemestane Alone in Elderly Patients With HER2-Negative, Hormone Receptor–Positive Breast Cancer in BOLERO-2  Academic Article
• Safety and efficacy of black cohosh (Cimicifuga racemosa) during pregnancy and lactation.  Academic Article
• Safety and efficacy of chastetree (Vitex agnus-castus) during pregnancy and lactation.  Academic Article
• Secretory Breast Carcinoma: Unique, Triple-Negative Carcinoma With a Favorable Prognosis and Characteristic Molecular Expression  Academic Article
• Serum testosterone levels and breast cancer recurrence  Academic Article
• Systematic Review on Hormone Receptor Testing in Breast Cancer  Academic Article
• Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study  Academic Article
• Systemic Adjuvant Therapy for Node-Negative Breast Cancer: Proven or Premature?  Academic Article
• Systemic adjuvant therapy for node-negative breast cancer.  Academic Article
• TAMOXIFEN PROPHYLAXIS  Academic Article
• Tailored targeted therapy for all: a realistic and worthwhile objective against  Academic Article
• Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015  Academic Article
• Tamoxifen Derivatives for Delivery of the Antitumoral (DACH)Pt Group: Selective Synthesis by McMurry Coupling, and Biochemical Behaviour  Academic Article
• Tamoxifen May Be an Effective Adjuvant Treatment for BRCA1-Related Breast Cancer Irrespective of Estrogen Receptor Status  Academic Article
• Tamoxifen therapy in premenopausal patients with metastatic breast cancer.  Academic Article
• The 21-gene recurrence score assay in node-negative early breast cancer: Prognostic, predictive or presumptuous?  Academic Article
• The First Organometallic Selective Estrogen Receptor Modulators (SERMs) and Their Relevance to Breast Cancer  Academic Article
• The Pattern of Glucocorticoid and Estrogen Receptors May Explain Differences in Steroid Dependency of Intrauterine Prostaglandin Production at Parturition in Sheep  Academic Article
• The best use of adjuvant endocrine treatments  Conference Paper
• The bioinorganic and medicinal chemistry of carboranes: from new drug discovery to molecular imaging and therapy  Academic Article
• The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures  Academic Article
• The rapid effects of estrogen: a mini-review  Academic Article
• The standardization of estrogen receptors  Academic Article
• The telomerase tale in vascular aging: regulation by estrogens and nitric oxide signaling  Academic Article
• Towards optimal endocrine therapy for hormone-sensitive breast cancer: Initial versus sequential adjuvant aromatase inhibition  Academic Article
• Treatment of estrogen deficiency symptoms in women surviving breast cancer - Part 6: Executive summary and consensus statement - Proceedings of a conference held at the Boar's Head Inn - Charlottesville, Virginia, September 21-23, 1997  Academic Article
• Treatment of estrogen deficiency symptoms in women surviving breast cancer. Part 5: Selective estrogen receptor modulators and hormone replacement therapy. Proceedings of a conference. Charlottesville, Virginia, USA. September 21-23, 1997.  Conference Paper
• Treatment of estrogen deficiency symptoms in women surviving breast cancer. Part 6: Executive summary and consensus statement. Proceedings of a conference held at Boar's Head Inn, Charlottesville, Virginia, September 21-23, 1997.  Conference Paper
• Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence  Academic Article
• Triple-negative breast cancer prevalence in Africa: a systematic review and meta-analysis  Academic Article
• UTILITY OF IN VITRO TEST METHODS TO ASSESS THE ACTIVITY OF XENOESTROGENS IN FISH  Academic Article
• Use of isoflavone supplements is associated with reduced postmenopausal breast cancer risk  Academic Article
• Zinc presence in invasive ductal carcinoma of the breast and its correlation with oestrogen receptor status  Academic Article
• [The significance of hormone receptor content in primary tumors for cytostatic therapy of advanced breast carcinoma].  Academic Article
• o,p′-DDT induction of vitellogenesis and its inhibition by tamoxifen in Nile tilapia (Oreochromis niloticus)  Academic Article